- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT01413282
Better Evaluation of Acute Chest Pain With Computed Tomography Angiography (BEACON)
Better Evaluation of Acute Chest Pain With Computed Tomography Angiography - A Randomized Controlled Trial
연구 개요
상세 설명
Myocardial infarction remains one of the most important causes of death and disability. Therefore it is important that individuals with acute chest pain are accurately assessed without delaying appropriate treatment. Acute coronary syndrome is only one cause for sudden chest pain, which is a very common complaint in the ER. Other life threatening causes such as pulmonary embolism and aortic dissection may also be the cause, although most chest discomfort has a benign reason (musculoskeletal, hyperventilation, oesophageal reflux, etc).
The current work-up of suspected acute coronary syndrome, based on presentation, symptoms, ECG and biomarkers, is not efficient and results in unnecessary diagnostics and hospital admissions, as well as errors or delayed diagnoses, in a substantial number of patients. Computed tomography angiography (CTA) images atherosclerosis, coronary obstruction as well as myocardial hypoperfusion. We hypothesize that early use of CTA is of incremental value and allows for accurate and immediate triage of patients with acute chest pain.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Rotterdam, 네덜란드
- Erasmus MC
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Acute chest pain or equivalent
- Patients older than 30 years
- Males < 75 years and Females < 80 years
Exclusion Criteria:
- STEMI
- Troponin > 0.1
- History of known myocardial infarction, PCI or CABG
- Pregnancy
- Contrast allergy
- Renal disfunction
- No informed consent possible
- No follow-up possible
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 특수 증상
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
활성 비교기: Cardiac CT
Triage based on cardiac CT results.
|
Calcium scan and CT coronary angiography
|
|
간섭 없음: Standard Care
Standard diagnostic management according to the European guidelines.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Successful discharge rate
기간: 30 days
|
The proportion of patients discharged home without major adverse events during the following 30 days.
Major adverse events are cardiovascular death or non-fatal myocardial infarction.
|
30 days
|
|
Diagnostic yield of invasive angiography
기간: 30 days
|
Number of patients identified with severe coronary artery disease identified by invasive angiography requiring revascularisation according to the international guidelines.
|
30 days
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Successful discharge rate for all adverse events
기간: 30 days
|
The proportion of patients discharged home without any adverse events during the following 30 days.
Adverse events are cardiovascular death, non-fatal myocardial infarction, unstable angina, coronary revascularization, repeat hospital visits for chest pain.
|
30 days
|
|
Major adverse events
기간: 6 months
|
Composite endpoint of major adverse cardiac events at 6 months: cardiovascular death, non-fatal myocardial infarction, unstable angina, coronary revascularisation and repeat hospital visits for chest pain.
|
6 months
|
|
Acute coronary syndrome
기간: Index hospital visit
|
Diagnosis of acute coronary syndrome, according to international guidelines, at time of discharge.
|
Index hospital visit
|
|
Missed myocardial infarctions
기간: 2 days
|
Missed myocardial infarctions, at 2-day follow-up, in patients discharged from the emergency department.
|
2 days
|
|
Duration of hospital stay
기간: Index hospital visit
|
Duration of hospital stay
|
Index hospital visit
|
|
Direct medical cost
기간: 30 days
|
Direct medical costs until 30th day after ED visit.
|
30 days
|
|
Radiation exposure
기간: 6 months
|
Cumulative medical radiation exposure at 6 months.
|
6 months
|
|
Renal function
기간: 2 days
|
Change in renal function after 2 days.
|
2 days
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Koen Nieman, MD, PhD, Erasmus MC
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
급성관상동맥증후군에 대한 임상 시험
-
Chinese Academy of Medical Sciences, Fuwai HospitalMedtronic; CCRF Consulting Co., Ltd.빼는Transradial-transfemoral Coronary Interventions 비교
-
CCRF Consulting Co., Ltd.Peking University First Hospital; Terumo Medical(shanghai) Co.,Ltd.알려지지 않은심장 또는 뇌혈관 질환 무료 요금 | Transradial-transfemoral Coronary Interventions 비교중국
-
Hospital Clinic of BarcelonaAstraZeneca완전한CTO(Chronic Total Occlusion)를 위한 PCI(Percutaneous Coronary Intervention)를 받을 예정인 환자스페인
-
Istanbul Medipol University Hospital완전한
-
Icahn School of Medicine at Mount SinaiNational Institute on Deafness and Other Communication Disorders (NIDCD)완전한
-
Beijing Friendship Hospital모병
-
Weill Medical College of Cornell UniversityNew York University; National Center for Complementary and Integrative Health (NCCIH)모병
-
Basaksehir Cam & Sakura Şehir Hospital완전한
-
Duke Street Bio Ltd모병Advanced Malignancies With Homologous Recombination Deficiency (HRD) (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Metastases)스페인, 프랑스, 헝가리, 미국
Cardiac CT에 대한 임상 시험
-
Medtronic Cardiac Ablation Solutions완전한
-
Medtronic Cardiac Rhythm and Heart FailureMedtronic International Trading Sarl완전한
-
Uppsala University HospitalMedtronic; Swedish Heart Lung Foundation알려지지 않은
-
Boston Scientific Corporation모집하지 않고 적극적으로빈맥, 심실 | 부정맥, 심실미국, 스페인, 이탈리아, 영국, 네덜란드, 프랑스, 체코, 오스트리아, 캐나다
-
Medtronic Cardiac Ablation Solutions완전한
-
Respicardia, Inc.완전한
-
Beijing Anzhen Hospital아직 모집하지 않음다혈관 관상 동맥 질환 | ST 상승 심근 경색증(STEMI) | ACS(급성 관상동맥 증후군) | 미세혈관 폐쇄(MVO)중국
-
University of Massachusetts, WorcesterNational Heart, Lung, and Blood Institute (NHLBI); Brigham and Women's Hospital; University... 그리고 다른 협력자들완전한